How often does Cosentyx (secukinumab) blood work monitoring happen?
For most people using Cosentyx (secukinumab), routine blood-work monitoring is not typically required in the way it is for some other inflammatory arthritis or psoriasis medicines. In standard practice, clinicians usually rely on scheduled clinical follow-ups and symptom review, rather than frequent lab panels.
That said, your blood-work plan can change based on what condition you’re treating and your other risk factors (for example, infections, liver or blood issues, or concurrent medications).
What labs might be checked, and when?
Even when routine frequent monitoring isn’t required, clinicians may order blood tests in certain situations, such as:
- Baseline labs or screening before starting therapy (especially if you have a history of infection, abnormal labs, or are on other systemic treatments).
- Follow-up labs if you develop symptoms that could suggest an infection or other complication.
- Additional testing when Cosentyx is used alongside other drugs that do require laboratory monitoring.
What if you’re also taking other medications?
If you’re using Cosentyx with medicines that require ongoing lab monitoring (for example, some immunosuppressants or other systemic therapies), your overall blood-work schedule usually follows the monitoring needs of those other drugs rather than Cosentyx alone.
When should you call your clinician about labs or symptoms?
Contact your clinician promptly if you develop signs of infection or other concerning symptoms that might prompt repeat testing (for example, fever, worsening infections, or feeling significantly unwell). Your clinician may decide whether blood work is needed based on what you’re experiencing.
Where can I confirm the recommended monitoring schedule?
For the most precise, label-aligned guidance, check the prescribing information for Cosentyx or confirm with your prescribing clinician. If you want, tell me whether you’re using Cosentyx for plaque psoriasis, psoriatic arthritis, or ankylosing spondylitis—and whether you’re on any other systemic medications—and I can narrow down what monitoring is commonly done in that scenario.
Sources
I don’t have enough provided information here to cite a specific Cosentyx “blood work frequency” schedule from approved labeling or DrugPatentWatch.com. If you share your indication and whether you’re on other meds, I can tailor the answer to what monitoring is typically needed.